Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Why These Stocks Are Trading Higher on Monday?

Stocks kicked off with a bullish trend on Monday morning after the long Easter weekend. The S&P 500 and Dow Jones Industrial Average are up by approximately 0.31% and 0.26%, respectively. Among the notable stocks which are rising today include Alder Biopharmaceuticals Inc (NASDAQ:ALDR), Sunedison Inc (NYSE:SUNE), Berkshire Hathaway Inc. (NYSE:BRK.A), ADT Corp (NYSE:ADT) and Starwood Hotels & Resorts Worldwide Inc (NYSE:HOT). Let’s dig deeper and see why these stocks are trading higher today.

At Insider Monkey, we track around 790 hedge funds and other institutional investors. Through extensive backtests, we have determined that imitating some of the stocks that these investors are collectively bullish on can help retail investors generate double digits of alpha per year. The key is to focus on the small-cap picks of these funds, which are usually less followed by the broader market and allow for larger price inefficiencies (see more details about our small-cap strategy).

Alder Biopharmaceuticals Inc (NASDAQ:ALDR)’s stock has surged by 17% after the company announced top-line data of ALD403, its drug for migraine. According to Randall C. Schatzman, the CEO of ALDR, the company has met the primary and secondary endpoints of Phase 2b ALD403 drug trial. At the end of the fourth quarter, 17 funds we track at Insider Monkey were bullish on Alder Biopharmaceuticals Inc (NASDAQ:ALDR), down from 23 funds a quarter earlier, while the total value their positions decreased to $235.21 million from $241.59 million and totaled 16.30% of the company’s stock. Billionaire Steve Cohen‘s Point72 Asset Management reported ownership of 1.28 million shares of Alder BioPharmaceuticals in its last 13F filing.

Follow Alder Biopharmaceuticals Inc (NASDAQ:ALDR)
Trade (NASDAQ:ALDR) Now!

On Monday morning, UBS assigned a “Buy” rating to Berkshire Hathaway Inc. (NYSE:BRK.A), with a price target of $244,500 per share. According to the analyst, Berkshire Hathaway’s relatively sloppy performance was due to problems in insurance and railroads. UBS says that Berkshire Hathaway Inc. (NYSE:BRK.A) has structural advantages which will help it grow its earnings. At the end of the fourth quarter, 75 investors from our database held shares of Berkshire Hathaway with a total value of $19.3 billion, versus  69 investors and $19.4 billion, respectively a quarter earlier. Bill & Melinda Gates Foundation Trust, managed by Michael Larson, owns approximately 74 million shares of Berkshire Hathaway.

Follow Berkshire Hathaway Inc (NYSE:BRK.A)
Trade (NYSE:BRK.A) Now!